Anticancer Properties of the Antipsychotic Drug Chlorpromazine and Its Synergism With Temozolomide in Restraining Human Glioblastoma Proliferation In Vitro

被引:27
作者
Matteoni, Silvia [1 ]
Matarrese, Paola [2 ]
Ascione, Barbara [2 ]
Buccarelli, Mariachiara [3 ]
Ricci-Vitiani, Lucia [3 ]
Pallini, Roberto [4 ]
Villani, Veronica [5 ]
Pace, Andrea [5 ]
Paggi, Marco G. [1 ]
Abbruzzese, Claudia [1 ]
机构
[1] IRCCS Regina Elena Natl Canc Inst, Prote Unit, Cellular Networks & Mol Therapeut Targets, Rome, Italy
[2] Ist Super Sanita, Oncol Unit, Ctr Gender Specif Med, Rome, Italy
[3] Ist Super Sanita, Dept Oncol & Mol Med, Rome, Italy
[4] Catholic Univ Sch Med, Inst Neurosurg, Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy
[5] IRCCS Regina Elena Natl Canc Inst, Neurooncol, Rome, Italy
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
glioblastoma; antipsychotic drugs (APDs); drug repurposing and repositioning; cancer stem cells (CSC); neurospheres; drug synergism; clinical trials; STEM-CELLS; DIFFERENTIATION; IDENTIFICATION; PHENOTHIAZINE; INHIBITION; EXPRESSION; AUTOPHAGY; DOPAMINE; SURVIVAL; PATHWAY;
D O I
10.3389/fonc.2021.635472
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The extremely poor prognosis of patients affected by glioblastoma (GBM, grade IV glioma) prompts the search for new and more effective therapies. In this regard, drug repurposing or repositioning can represent a safe, swift, and inexpensive way to bring novel pharmacological approaches from bench to bedside. Chlorpromazine, a medication used since six decades for the therapy of psychiatric disorders, shows in vitro several features that make it eligible for repositioning in cancer therapy. Using six GBM cell lines, three of which growing as patient-derived neurospheres and displaying stem-like properties, we found that chlorpromazine was able to inhibit viability in an apoptosis-independent way, induce hyperdiploidy, reduce cloning efficiency as well as neurosphere formation and downregulate the expression of stemness genes in all these cell lines. Notably, chlorpromazine synergized with temozolomide, the first-line therapeutic in GBM patients, in hindering GBM cell viability, and both drugs strongly cooperated in reducing cloning efficiency and inducing cell death in vitro for all the GBM cell lines assayed. These results prompted us to start a Phase II clinical trial on GBM patients (EudraCT # 2019-001988-75; ClinicalTrials.gov Identifier: NCT04224441) by adding chlorpromazine to temozolomide in the adjuvant phase of the standard first-line therapeutic protocol.
引用
收藏
页数:12
相关论文
共 49 条
  • [1] Repurposing chlorpromazine in the treatment of glioblastoma multiforme: analysis of literature and forthcoming steps
    Abbruzzese, Claudia
    Matteoni, Silvia
    Persico, Michele
    Villani, Veronica
    Paggi, Marco G.
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [2] The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiforme
    Abbruzzese, Claudia
    Catalogna, Giada
    Gallo, Enzo
    di Martino, Simona
    Mileo, Anna M.
    Carosi, Mariantonia
    Dattilo, Vincenzo
    Schenone, Silvia
    Musumeci, Francesca
    Lavia, Patrizia
    Perrotti, Nicola
    Amato, Rosario
    Paggi, Marco G.
    [J]. ONCOTARGET, 2017, 8 (67) : 110743 - 110755
  • [3] Drug repurposing for the treatment of glioblastoma multiforme
    Abbruzzese, Claudia
    Matteoni, Silvia
    Signore, Michele
    Cardone, Luca
    Nath, Kavindra
    Glickson, Jerry D.
    Paggi, Marco G.
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36
  • [4] Inhibition of the NMDA and AMPA receptor channels by antidepressants and antipsychotics
    Barygin, Oleg I.
    Nagaeva, Elina I.
    Tikhonov, Denis B.
    Belinskaya, Darya A.
    Vanchakova, Nina P.
    Shestakova, Natalia N.
    [J]. BRAIN RESEARCH, 2017, 1660 : 58 - 66
  • [5] The Physiology, Signaling, and Pharmacology of Dopamine Receptors
    Beaulieu, Jean-Martin
    Gainetdinov, Raul R.
    [J]. PHARMACOLOGICAL REVIEWS, 2011, 63 (01) : 182 - 217
  • [6] Classics in Chemical Neuroscience: Chlorpromazine
    Boyd-Kimball, Debra
    Gonczy, Katelyn
    Lewis, Benjamin
    Mason, Thomas
    Siliko, Nicole
    Wolfe, Jacob
    [J]. ACS CHEMICAL NEUROSCIENCE, 2019, 10 (01): : 79 - 88
  • [7] Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis
    Buccarelli, Mariachiara
    Marconi, Matteo
    Pacioni, Simone
    De Pasqualis, Ivana
    D'Alessandris, Quintino Giorgio
    Martini, Maurizio
    Ascione, Barbara
    Malorni, Walter
    Larocca, Luigi Maria
    Pallini, Roberto
    Ricci-Vitiani, Lucia
    Matarrese, Paola
    [J]. CELL DEATH & DISEASE, 2018, 9
  • [8] Activation of Dopamine Receptor 2 Prompts Transcriptomic and Metabolic Plasticity in Glioblastoma
    Caragher, Seamus P.
    Shireman, Jack M.
    Huang, Mei
    Miska, Jason
    Atashi, Fatemeh
    Baisiwala, Shivani
    Park, Cheol Hong
    Saathoff, Miranda R.
    Warnke, Louisa
    Xiao, Ting
    Lesniak, Maciej S.
    James, C. David
    Meltzer, Herbert
    Tryba, Andrew K.
    Ahmed, Atique U.
    [J]. JOURNAL OF NEUROSCIENCE, 2019, 39 (11) : 1982 - 1993
  • [9] Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data
    Cheng, H-W
    Liang, Y-H
    Kuo, Y-L
    Chuu, C-P
    Lin, C-Y
    Lee, M-H
    Wu, A. T. H.
    Yeh, C-T
    Chen, E. I-T
    Whang-Peng, J.
    Su, C-L
    Huang, C-Y F.
    [J]. CELL DEATH & DISEASE, 2015, 6 : e1753 - e1753
  • [10] Potential therapeutic implications of cancer stem cells in glioblastoma
    Cheng, Lin
    Bao, Shideng
    Rich, Jeremy N.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2010, 80 (05) : 654 - 665